Post Profile

People Infected by Hepatitis C in Canada Have Limited Access to Direct-Acting Antivirals

A study conducted by Canadian and Australian researchers shows that nearly everywhere in Canada, the provinces and territories impose obstacles to reimbursement of new direct-acting antivirals (DAA) to treat hepatitis C by because of their cost.
read more


Related Posts

Studies Show Encouraging Data In A Wide Range Of HCV Patient Populations

Health : Medical News Today

New data from a number of clinical trials presented for the first time at the International Liver Congress™ 2013 demonstrate encouraging results in the use of new direct-acting antiviral agents (DAAs) for the treatment of hepatitis ...

Antiviral Therapy To Treat Hepatitis C Is Declining In The US, An Alarming Trend

Health : Medical News Today

Researchers from the University of Michigan determined that only 663,000 of the approximately 3.9 million Americans with hepatitis C virus (HCV) infection received antiviral therapy between 2002 and 2007. Treatment rates appear to b...

Arrival Of Direct Antiviral Agent Therapy For Hepatitis C Sparks Debate Of Who To Treat First

Health : Medical News Today

For many patients with the hepatitis C virus (HCV), direct antiviral agents (DAA) offer a potential cure for the disease. The Food and Drug Administration (FDA) has recently approved two new DAAs, telaprevir and boceprevir, and with...

Hepatitis C New Study On Drug Treatment In Vivo And In Vitro

Health : Medical News Today

Hepatitis C virus (HCV) infection affects about 4.1 million in the United States and is the primary cause of liver cirrhosis and liver cancer. Current therapy against HCV is suboptimal. Daclatasvir, a direct acting antiviral (DAA) a...

People infected by hepatitis C in Canada have limited access to direct-acting antivirals

Health : EurekAlert: Health

(University of Montreal Hospital Research Centre (CRCHUM) ) The new direct-acting antivirals (DAA) are effective in curing the hepatitis C virus infection, a potentially fatal disease that attacks the liver. But they are expensive--...


Copyright © 2016 Regator, LLC